IASLC Lung Cancer News | News about lung cancer research, patient care, tobacco control, and expert commentary from lung cancer leaders

Uncommon Oncogenic Drivers in NSCLC

lungcanc

Breaking News Briefs

IMpower133: Finally Moving the Needle in SCLC

The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?

Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung...

lungcanc

By Michael MacManus, MD, FRANZCR, and Tim Akhurst, MD, FRACP Posted: March 1, 2019 18F-FDG PET/CT scans portray living biology and are indispensable in thoracic oncologic...

Lung Cancer Pathology Pioneer Dr. Adi Gazdar Dies at 81

lungcanc

Posted: March 1, 2019 Adi Gazdar, MD, a true giant in the field of lung cancer research, passed away on December 29, 2018. Dr. Gazdar...

The Changing the Landscape of Tobacco Products: Potential Effects of ENDS...

Diagnostic Oncology: Reports from the IASLC Pathology Committee

Dr. Jamie E. Chaft Discusses Emerging Data on Induction Immunotherapy for...

An Interview with Dr. Federico Cappuzzo: Checkpoint Inhibitors Have Replaced Old...

IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...

The IASLC’s Spotlight on Screening

Advocacy & Survivorship

Improving Clinical Trials Through Clinician, Patient Use of Social Media

lungcanc

By DR Camidge Posted: March 1, 2019 The National Cancer Institute featured a workshop in June 2018 titled “At the Crossroads of Social Media and Clinical...

Nursing Care’s Technological Patient-Care Transformation

After the Consultation: Social Media, Inter-Patient Communication, and Clinical Trials

Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer

The Lung Cancer Research Foundation and Free to Breathe Merge to...

Meeting News

IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...

lungcanc

By Charles M. Rudin, MD, PhD Posted: March 1, 2019 2019 IASLC Small Cell Lung Cancer Meeting April 3-5 • New York, New York Memorial Sloan Kettering Cancer...